CIA
AZN icon

Cohen Investment Advisors’s AstraZeneca AZN Stock Holding History

Cohen Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$689K Sell
3,557
-31
-0.9% -$5.98K 0.33% 49
2025
Q4 		$660K Sell
3,588
-52
-1% -$9.12K 0.3% 48
2025
Q3 		$558K Buy
3,640
+138
+4% +$20.9K 0.27% 51
2025
Q2 		$489K Sell
3,502
-146
-4% -$20.5K 0.26% 54
2025
Q1 		$536K Buy
3,648
+33
+0.9% +$4.77K 0.31% 51
2024
Q4 		$474K Buy
3,615
+130
+4% +$18.2K 0.29% 56
2024
Q3 		$543K Sell
3,485
-777
-18% -$125K 0.33% 49
2024
Q2 		$577K Buy
4,262
+460
+12% +$69.2K 0.46% 46
2024
Q1 		$515K Sell
3,802
-141
-4% -$18.7K 0.33% 50
2023
Q4 		$531K Sell
3,943
-319
-7% -$41.5K 0.39% 49
2023
Q3 		$577K Sell
4,262
-304
-7% -$41.5K 0.46% 46
2023
Q2 		$654K Hold
4,566
– – 0.53% 45
2023
Q1 		$634K Sell
4,566
-35
-0.8% -$4.71K 0.5% 46
2022
Q4 		$624K Buy
4,601
+156
+4% +$19.6K 0.52% 45
2022
Q3 		$487K Sell
4,445
-244
-5% -$31K 0.45% 49
2022
Q2 		$620K Sell
4,689
-58
-1% -$7.61K 0.53% 44
2022
Q1 		$630K Buy
4,747
+46
+1% +$5.52K 0.47% 47
2021
Q4 		$548K Sell
4,701
-4
-0.1% -$471 0.39% 50
2021
Q3 		$565K Buy
4,705
+16
+0.3% +$1.86K 0.43% 47
2021
Q2 		$562K Buy
4,689
+20
+0.4% +$2.19K 0.44% 45
2021
Q1 		$464K Sell
4,669
-42
-0.9% -$4.22K 0.38% 49
2020
Q4 		$471K Buy
+4,711
New +$499K 0.43% 47

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Cohen Investment Advisors's AZN Position: Q1 2026 in Review

Cohen Investment Advisors reduced its AstraZeneca (AZN) stake by 0.86% in Q1 2026, selling an estimated $5.98K and leaving 3,557 shares worth $689K. The position accounts for 0.33% of the portfolio, ranked #49.

Cohen Investment Advisors first reported a position in AZN in Q4 2020 and has held it in 22 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Cohen Investment Advisors held 3,557 shares of AstraZeneca worth $689K as of Q1 2026.
  • Cohen Investment Advisors sold 31 AstraZeneca shares in Q1 2026, an estimated $5.98K.
  • AstraZeneca made up 0.33% of Cohen Investment Advisors's portfolio in Q1 2026, its #49 holding.
  • Cohen Investment Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 22 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Cohen Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.